Metraipolis › archive › dc_96e90ad91038

Prognostic utility of circulating tumor DNA assessment in immune checkpoint inhibitor-treated advanced non-small cell lung cancer: a systematic review and… — Europe PMC PMID:42344896

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42344896
DOI
10.3389/fimmu.2026.1812209
License (as archived)
solo-consultazione
Archived
2026-10-31T15:52:35.726Z
SHA-256 of the archived text
913a9a4ed7af7385ed8cfdc9e78fdc2378c497e3e56679c5105dc362a245326b
Stable URL of this page
https://metraipolis.com/documento/dc_96e90ad91038

How to cite

Prognostic utility of circulating tumor DNA assessment in immune checkpoint inhibitor-treated advanced non-small cell lung cancer: a systematic review and… — Europe PMC PMID:42344896 — Europe PMC (en), https://europepmc.org/article/MED/42344896 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96e90ad91038 (Metraipolis archive dc_96e90ad91038, sha256 913a9a4ed7af7385ed8cfdc9e78fdc2378c497e3e56679c5105dc362a245326b)
BibTeX
@misc{dc96e90ad91038,
  title = {Prognostic utility of circulating tumor DNA assessment in immune checkpoint inhibitor-treated advanced non-small cell lung cancer: a systematic review and… — Europe PMC PMID:42344896},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42344896},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96e90ad91038; sha256 913a9a4ed7af7385ed8cfdc9e78fdc2378c497e3e56679c5105dc362a245326b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344896. Agents can read the archived copy with the MCP tool read_document.